Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.9%

1 terminated out of 35 trials

Success Rate

94.4%

+7.9% vs benchmark

Late-Stage Pipeline

23%

8 trials in Phase 3/4

Results Transparency

24%

4 of 17 completed with results

Key Signals

4 with results94% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (7)
P 2 (2)
P 3 (6)
P 4 (2)

Trial Status

Completed17
Unknown8
Recruiting5
Not Yet Recruiting2
Suspended1
Active Not Recruiting1

Trial Success Rate

94.4%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (35)

Showing 20 of 20 trials
NCT05714085Phase 2Recruiting

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

NCT07192952Phase 3Not Yet RecruitingPrimary

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

NCT07188805Phase 3RecruitingPrimary

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

NCT06770062RecruitingPrimary

Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study

NCT04166331Phase 3Completed

Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion

NCT06270498Phase 4Recruiting

Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure

NCT05764109CompletedPrimary

Adherence to Cied Implantation Guidelines and Cardiac Rehabilitation

NCT04231331Phase 3Completed

Ertugliflozin for Functional Mitral Regurgitation

NCT04249648Completed

Hyperkalaemia and Its Impact on Therapy with RAASi

NCT05630170Not ApplicableCompletedPrimary

The SMART-LV Pilot Study

NCT06221891Recruiting

Early Evaluation of Left Ventricular Systolic Function Impairment in Patients With Chronic Kidney Disease by Multimodal Ultrasonography

NCT05647577Active Not Recruiting

The Relationship Between Inflammatory ARTritis and CArdiac DIseAse

NCT06231797UnknownPrimary

AI-ECG Screening for Left Ventricular Systolic Dysfunction

NCT05861115Not ApplicableCompletedPrimary

A Study to Evaluate Accuracy and Validity of the "Chang Gung" Ventricular Systolic Dysfunction Screening Software

NCT03470155Completed

Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function

NCT04221763Not ApplicableCompleted

Mechanisms and Innovations in Cardiac Resynchronisation Therapy

NCT01918215Not ApplicableUnknown

Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

NCT04963686UnknownPrimary

Simplified Assessment of Left Ventricular Systolic Function in Septic Shock Patients

NCT02642562Phase 4Completed

Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN

NCT01842035Not ApplicableCompletedPrimary

Heart Rate Response to Regadenoson and Sudden Cardiac Death

Scroll to load more

Research Network

Activity Timeline